choline has been researched along with fluorodeoxyglucose f18 in 186 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.08) | 18.7374 |
| 1990's | 3 (1.61) | 18.2507 |
| 2000's | 59 (31.72) | 29.6817 |
| 2010's | 104 (55.91) | 24.3611 |
| 2020's | 18 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Cambon, H; Crouzel, C; Duverger, D; Kiyosawa, M; MacKenzie, ET; Mazoyer, B; Naquet, R; Pappata, S; Riche, D; Samson, Y | 1 |
| Pastan, I; Seth, P; Willingham, MC | 1 |
| Alger, JR; Bonavita, S; Di Chiro, G; Duyn, JH; Lundbom, N; Raman, R; Tedeschi, G | 1 |
| Hara, T; Kishi, H; Kosaka, N | 1 |
| Hara, T; Kirihara, Y; Kobori, O; Kosaka, N | 1 |
| Hara, T; Inagaki, K; Kosaka, N; Morita, T | 1 |
| Baldwin, SW; Coleman, RE; DeGrado, TR; Orr, MD; Polascik, TJ; Price, DT; Robertson, CN; Wang, S | 1 |
| Inoue, T; Ishiuchi, S; Kurihara, H; Ohtani, T; Oriuchi, N; Saito, N; Sasaki, T | 1 |
| Elsinga, P; Jager, PL; Plukker, JT; Pruim, J; Que, TH; Vaalburg, W | 1 |
| Elsinga, PH; Groen, HJ; Pieterman, RM; Pruim, J; Que, TH; Vaalburg, W; van Putten, JW; Willemsen, AT | 1 |
| Coleman, RE; DeGrado, TR; Liao, RP; Polascik, TJ; Price, DT; Robertson, CN | 1 |
| De Cobelli, F; Fazio, F; Gianolli, L; Landoni, C; Maschio, AD; Matarrese, M; Messa, C; Picchio, M | 1 |
| Kawana, A; Kobayashi, N; Kudo, K; Morita, T; Nomura, T; Takeda, Y; Tsuduki, E | 1 |
| Ackermann, R; Coenen, HH; Hautzel, H; Herzog, H; Krause, BJ; Müller-Gärtner, HW; Müller-Mattheis, V; Roden, W | 1 |
| Aoki, J; Endo, K; Higuchi, T; Oriuchi, N; Tanada, S; Tian, M; Watanabe, H; Zhang, H | 1 |
| Brioschi, M; De Cobelli, F; Del Maschio, A; Fazio, F; Gianolli, L; Landoni, C; Matarrese, M; Matei, DV; Messa, C; Picchio, M; Rigatti, P; Rocco, F; Sironi, S | 1 |
| Endo, K; Higuchi, T; Inoue, T; Khan, N; Oriuchi, N; Sato, N; Tian, M; Zhang, H | 1 |
| Bénard, F; Hustinx, R; Romsa, J | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Hara, T; Kosaka, N; Kudo, K; Niino, H; Suzuki, T | 1 |
| Lehikoinen, P; Minn, H; Möttönen, T; Nuutila, P; Parkkola, R; Roivainen, A; Viljanen, T; Yli-Kerttula, T | 1 |
| Ametamey, SM; Bode, B; Buck, A; Honer, M; Kaim, AH; Späth, N; Weber, B; Westera, G; Wyss, MT | 1 |
| Sasaki, T | 1 |
| Endo, K; Higuchi, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Chikamatsu, K; Endo, K; Furuya, N; Higuchi, T; Kahn, N; Kamada, H; Ninomiya, H; Oriuchi, N; Takahashi, K | 1 |
| Beal, MF; Brownell, AL; Chen, YI; Cicchetti, F; Dedeoglu, A; Jenkins, BG; Wang, X; Yu, M | 1 |
| Guo, J; Higashi, K; Kodama, Y; Nagao, Y; Oguchi, M; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I; Yokota, H | 1 |
| Endo, K; Higuchi, T; Kamada, H; Khan, N; Ninomiya, H; Oriuchi, N | 1 |
| Fogelman, I; Heinisch, M; Langsteger, W | 1 |
| Ametamey, SM; Buck, A; Kaufmann, PA; Lacal, JC; Lohmann, C; Lüscher, TF; Matter, CM; Meier, P; Ramirez de Molina, A; Späth, N; von Lukowicz, T; von Schulthess, GK; Weber, B; Wyss, MT | 1 |
| Attuati, L; Bettinardi, V; Fazio, F; Ferrari da Passano, C; Franzin, A; Landoni, C; Messa, C; Picozzi, P; Rizzo, G | 1 |
| Biollaz, G; Buck, A; Goepfert, K; Lutz, A; Pahnke, J; Spaeth, N; Treyer, V; Weber, B; Westera, G; Wyss, MT | 1 |
| Bolton, DM; Davis, ID; Lawrentschuk, N; Scott, AM | 1 |
| Fartoux, L; Ganne, N; Grahek, D; Grange, JD; Gutman, F; Kerrou, K; Montravers, F; Poupon, R; Rosmorduc, O; Talbot, JN | 1 |
| Al-Nahhas, A; Fanti, S; Nanni, C; Rubello, D | 1 |
| Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E | 1 |
| Balkay, L; Friedlander, E; Krasznai, Z; Márián, T; Németh, E; Szabó, A; Szabó-Péli, J; Trón, L; Veress, G | 1 |
| Bansal, A; DeGrado, TR; Hara, T | 1 |
| Dezortova, M; Hajek, M; Jiru, F; Komarek, V; Krsek, P; Kyncl, M; Marusic, P; Skoch, A; Tichy, M; Zamecnik, J | 1 |
| Albrecht, S; Buchegger, F; Hany, TF; Husarik, D; Khan, H; Miralbell, R; Soloviev, D; Vees, H; Zaidi, H | 1 |
| Balogova, S; Cussenot, O; Gattegno, B; Grahek, D; Gutman, F; Huchet, V; Kerrou, K; Kerrouche, N; Montravers, F; Talbot, JN; Thibault, P | 1 |
| Al-Nahhas, A; Alavi, A; Ambrosini, V; Fanti, S; Franchi, R; Nanni, C; Pettinato, C; Rubello, D; Spinelli, A; Trespidi, S | 1 |
| Coel, MN; Jiang, CS; Ko, JP; Kwee, SA; Watters, MR | 1 |
| Al-Nahhas, A; Ambrosini, V; Castellucci, P; Cavo, M; Fanti, S; Farsad, M; Franchi, R; Montini, GC; Nanni, C; Pettinato, C; Rubello, D; Tacchetti, P; Zamagni, E | 1 |
| Ell, PJ; Groves, AM; Haim, SB; Win, T | 1 |
| Vallabhajosula, S | 1 |
| Borson-Chazot, F; Chayvialle, JA; Janier, M; Kryza, D; Le Bars, D; Nejjari, M; Perek, N; Poncet, G; Roche, C; Scoazec, JY | 1 |
| Filannino, MA; Kryza, D; Lemoucheux, L; Tadino, V; Villeret, G | 1 |
| Guan, Y; Huang, Z; Lin, X; Liu, P; Xue, F; Zhang, Z; Zuo, C | 1 |
| Iwama, T; Kato, T; Maruyama, T; Miwa, K; Muragaki, Y; Nakayama, N; Okumura, A; Shinoda, J; Yano, H; Yoshimura, S | 1 |
| Chida, K; Inui, N; Miwa, S; Miyazaki, H; Suda, T; Torizuka, T | 1 |
| Deguchi, A; Kaji, M; Kameyama, R; Kashiwagi, H; Nishiyama, Y; Ohkawa, M; Okano, K; Yamamoto, Y | 1 |
| Abe, S; Fukuma, E; Higa, K; Kawano, N; O'uchi, T; Ogawa, T; Oyama, Y; Ozaki, S; Sakamoto, M; Sakamoto, N; Suzuki, T; Tozaki, M; Yamashiro, N | 1 |
| Allegri, V; Astorino, M; Biasco, G; Boschi, S; Brandi, G; Castellucci, P; Di Battista, M; Fanti, S; Lodi, F; Lopci, E; Maleddu, A; Nanni, C; Nannini, M; Pantaleo, MA | 1 |
| Bertaccini, A; Borghesi, M; Brunocilla, E; Castellucci, P; Concetti, S; Fanti, S; Farsad, M; Franceschelli, A; Franchi, R; Garofalo, M; Manferrari, F; Martorana, G; Nanni, C; Rocca, C; Sanguedolce, F; Schiavina, R | 1 |
| Alexiou, GA; Fotopoulos, AD; Kyritsis, AP; Polyzoidis, KS; Tsiouris, S; Voulgaris, S | 1 |
| Kuang, Y; Lee, Z; Maclennan, GT; Salem, N; Wang, F | 1 |
| Attuati, L; Fallanca, F; Fazio, F; Gianolli, L; Giovacchini, G; Landoni, C; Messa, C; Picchio, M; Picozzi, P; Terreni, M | 1 |
| Belloli, S; Bellone, M; Fazio, F; Freschi, M; Hess Michelini, R; Jachetti, E; Lecchi, M; Moresco, RM; Picchio, M; Valtorta, S | 1 |
| Emonds, KM; Mortelmans, L; Mottaghy, FM; Swinnen, JV | 1 |
| García-Velloso, MJ; Garrastachu, P; Martí-Climent, J; Peñuelas, I; Quincoces, G; Richter, JA; Rioja, J; Rodríguez, M; Zudaire, J | 1 |
| Abe, Y; Ishihara, T; Katayama, S; Kubo, J; Kumagai, T; Soeda, T; Tanno, Y; Yamamoto, T | 1 |
| Galuska, L; Goda, K; Hernádi, Z; Krasznai, Z; Krasznai, ZT; Márián, T; Mikecz, P; Miklovicz, T; Tóth, A; Trón, L | 1 |
| Gauthier, H | 1 |
| Berián Polo, JM; Martínez-Monge, R; Richter, JA; Rincón Mayans, A; Rioja Zuazu, J; Rodríguez, M; Sansi, AS; Zudaire Bergera, JJ | 1 |
| Antoine, M; Balogova, S; Cadranel, J; Gutman, F; Huchet, V; Kerrou, K; Lavolée, A; Mayaud, C; Montravers, F; Nataf, V; Prignon, A; Ruppert, AM; Talbot, JN | 1 |
| Ito, K; Kubota, K; Matsuda, H; Morooka, M; Shiibashi, M; Yokoyama, J | 1 |
| Bae, KT; Goshima, S; Hoshi, H; Kako, N; Kanematsu, M; Kondo, H; Watanabe, H; Yamada, T; Yamamoto, N | 1 |
| Beauregard, JM; Degrado, TR; Hicks, RJ; Roselt, P; Williams, SG | 1 |
| Ito, K; Kubota, K; Morooka, M; Yokoyama, J | 1 |
| Burkholder, I; Combs, SE; Essig, M; Giesel, FL; Haberkorn, U; Henze, M; Kauczor, HU; Kroll, A; Meissner, M; Stieltjes, B; Tüttenberg, J; Vogt-Schaden, M; Weber, MA; Zimmer, F; Zoubaa, S | 1 |
| Ancel, D; Balogova, S; Fartoux, L; Grange, JD; Gutman, F; Huchet, V; Kerrou, K; Nataf, V; Rosmorduc, O; Talbot, JN | 1 |
| Jadvar, H | 2 |
| Corn, DJ; Kolthammer, JA; Kuang, Y; Lee, Z; Salem, N; Tian, H; Wang, F; Wang, Y; Wu, C | 1 |
| Li, HS; Wang, MF; Wang, QS; Wu, HB | 1 |
| Hara, T; Hasuo, K; Ito, K; Kubota, K; Morooka, M; Okamoto, K | 1 |
| Fury, MG; Jansen, JF; Koutcher, JA; Lee, NY; Patel, SG; Pfister, DG; Schöder, H; Shah, JP; Shukla-Dave, A; Stambuk, HE; Wang, Y | 1 |
| Li, HS; Wang, MF; Wang, QS; Wu, HB; Zhen, X; Zhou, WL | 1 |
| Lee, D; Shim, H; Zhu, A | 1 |
| Aki, T; Asano, Y; Ito, T; Iwama, T; Miwa, K; Shinoda, J; Takenaka, S; Yokoyama, K | 1 |
| Bolton, D; Chang, JH; Clouston, D; Davis, ID; Gong, SJ; Hamilton, CS; Joon, DL; Khoo, V; Lee, ST; Scott, AM | 1 |
| Baniel, J; Golan, S; Groshar, D; Sopov, V | 1 |
| Emonds, KM; Mortelmans, L; Mottaghy, FM; Nuyts, J; Swinnen, JV; van Weerden, WM; Vanderhoydonc, F | 1 |
| Endo, K; Tian, M; Zhang, H | 1 |
| Calaminus, C; Duchamp, O; Honndorf, VS; Judenhofer, MS; Kukuk, D; Machulla, HJ; Pichler, BJ; Quintanilla-Martinez, L; Raguin, O; Reischl, G; Schönberger, T; Wiehr, S | 1 |
| Aboagye, EO; Al-Nahhas, A; Challapalli, A; Contractor, KB; Coombes, RC; De Nguyen, Q; Hogben, K; Kenny, LM; Lewis, JS; Palmieri, C; Shousha, S; Stebbing, J | 1 |
| Cheng, X; Cui, R; Li, F; Zhuang, H | 1 |
| Artemov, D; Bhujwalla, ZM; Gadiya, MM; Krishnamachary, B; Nimmagadda, S; Penet, MF; Pomper, MG | 1 |
| Chen, L; Guan, Y; Lin, X; Tan, H | 1 |
| Li, BY; Li, HS; Wang, QS; Wang, QY; Wu, HB; Zhou, WL | 1 |
| Bartenstein, P; Cumming, P; Graute, V; Hacker, M; Hartenbach, M; Jansen, N; Klanke, K; Scherr, MK; Seitz, M; Thieme, S; Tiling, R; Ubleis, C | 1 |
| Aboagye, EO; Alam, IS; Awais, RO; Brickute, D; Carroll, L; Nguyen, QD; Smith, G; Tomasi, G; Turton, DR; Twyman, FJ; Witney, TH | 1 |
| Fujimaki, M; Hanaguri, M; Ikeda, K; Ito, S; Kazuo, K; Ohba, S; Yazawa, M; Yokoyama, J; Yoshimoto, H | 1 |
| Marcus, DM; Shim, H; Shu, HK; Zhu, A | 1 |
| Chung, JH; Im, KC; Kang, JK; Kim, JS; Kim, KS; Kim, ST; Kim, YI; Lee, EM; Park, GY; Shon, YM; Woo, CW | 1 |
| Bjartell, A; Evans-Axelsson, S; Hagman, Z; Lilja, H; Nilsson, O; Olsson, T; Örbom, A; Peterson, P; Strand, J; Strand, SE; Tolmachev, V; Ulmert, D; Wennerberg, J; Wingårdh, K | 1 |
| Balogova, S; Fartoux, L; Huchet, V; Kerrou, K; Nataf, V; Rosmorduc, O; Talbot, JN | 1 |
| Angelidis, G; Georgoulias, P; Leondi, A; Psimadas, D; Valotassiou, V | 1 |
| Akashi-Tanaka, S; Daisaki, H; Kano, D; Kinoshita, T; Macapinlac, HA; Murano, T; Tateishi, U; Terauchi, T; Tsuda, H | 1 |
| Achten, E; Acou, M; Goethals, I; Mertens, K; Nuyts, R; Van den Broecke, C; Van Roost, D | 1 |
| Alsac, JM; Boisgard, R; Hervatin, F; Le Guludec, D; Michel, JB; Montravers, F; Sarda-Mantel, L; Tavitian, B | 1 |
| Buchegger, F; Chouiter, A; Dipasquale, G; Miralbell, R; Namy, S; Ratib, O; Steiner, C; Vees, H; Velazquez, M; Zilli, T | 1 |
| Li, M; Liu, Q; Peng, Z; Sun, J; Yao, S | 1 |
| Cascini, GL; Cuccurullo, V; Mansi, L; Rotondo, A; Tamburrini, O | 1 |
| Amrami, KK; Babu, MA; Dyck, PJ; Howe, BM; Kawashima, A; Nathan, MA; Spinner, RJ | 1 |
| Bolton, D; Chan, JG; Chang, JH; Clouston, D; Davis, ID; Esler, S; Goh, YP; Gong, SJ; Hiew, CY; Khoo, V; Lee, ST; Lim Joon, D; O'Sullivan, R; Scott, AM; Tochon-Danguy, H; Wada, M | 1 |
| Asano, Y; Iwama, T; Miwa, K; Nomura, Y; Shinoda, J; Takenaka, S; Yano, H; Yonezawa, S | 1 |
| Balogova, S; Decazes, P; Fartoux, L; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Rosmorduc, O; Talbot, JN; Vereb, M | 1 |
| Heusch, P; Lauenstein, TC; Lipponer, C; Nagarajah, J; Nensa, F; Pöppel, TD; Rübben, H; Schlosser, TW; Wetter, A | 1 |
| Delcuratolo, M; Iftner, T; Kolb, A; Mantlik, F; Münch, P; Pichler, BJ; Probst, S; Schmidt, H; Stubenrauch, F; Wiehr, S | 1 |
| Buck, AK; Donat, U; Israel, I; Richter, D; Samnick, S; Stritzker, J; van Ooschot, M | 1 |
| Hu, K; Huang, T; Liang, X; Nie, D; Sun, T; Tang, G; Tang, X; Wang, H | 1 |
| Beck, T; Grosu, AL; Jilg, CA; Meyer, PT; Rischke, HC; Schultze-Seemann, W; Vach, W; Wieser, G | 1 |
| Alongi, P; Bomanji, JB; Fraioli, F; Gaze, MN; Groves, AM; Hargrave, D; Hyare, H; Michopoulou, S; Shankar, A; Stoneham, S; Syed, R | 1 |
| Brunotte, F; Cochet, A; Cormier, L; Créhange, G; Humbert, O; Kanoun, S; Walker, PM | 1 |
| Bolcaen, J; Boterberg, T; De Vos Pharm, F; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Kalala, JP; Leybaert, L; Van den Broecke, C; Vanhove, C | 1 |
| Ciarmiello, A; Gaeta, MC; Giovannini, E; Lazzeri, P; Milano, A | 1 |
| Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R | 1 |
| Bijnsdorp, IV; Geldof, AA; Hoekstra, OS; Oprea-Lager, DE; van de Ven, PM; van den Eertwegh, AJ; van Kanten, MP; van Moorselaar, RJ | 1 |
| ten Kate, RW; van Raalte, DH; Vlot, MC; Zwijnenburg, A | 1 |
| Berczi, C; Farkas, B; Flaskó, T; Galuska, L; Garai, I; Oszlánszki, A | 1 |
| Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T | 1 |
| Bolton, D; Chang, JH; Clouston, D; Davis, ID; Esler, S; Goh, YP; Gong, SJ; Hiew, CY; Khoo, V; Lee, ST; Lim Joon, D; O'Sullivan, R; Scott, AM; Wada, M | 1 |
| Colombié, M; Goineau, A; Rousseau, C; Sadot-Lebouvier, S; Supiot, S | 1 |
| Banzo, I; Carril, JM; Jiménez-Bonilla, J; Martínez-Rodríguez, I; Quirce, R | 1 |
| Arlandini, A; Bandelloni, R; Foppiani, L; Massollo, M; Piccardo, A | 1 |
| Hwang, GY; Leung, GK; Li, LF; Lui, WM; Pu, JK; Taw, BB | 1 |
| Chen, W; Feng, Q; Huang, M; Jiang, J; Wang, Q; Wu, H; Wu, Y; Yang, W; Zhao, J | 1 |
| Asti, M; Cavuto, S; De Berti, G; Erba, PA; Filice, A; Fraternali, A; Froio, A; Iaccarino, C; Iori, M; Pisanello, A; Sghedoni, R; Sollini, M; Versari, A | 1 |
| Duan, Z; Jiao, G; Lei, J; Ouyang, Q | 1 |
| Cook, GJ; Corrigan, AJ; Schleyer, PJ | 1 |
| Agostini, H; Castilla-Lièvre, MA; Désarnaud, S; Franco, D; Gervais, P; Helal, BO; Kuhnast, B; Marthey, L | 1 |
| Aprile, C; Buroni, FE; Lodola, L; Nano, R; Pasi, F; Persico, MG | 1 |
| Aide, N; Allouache, N; Dugué, AE; How Kit, N; Joly, F; Lesaunier, F; Sevin, E | 1 |
| Chow, PK; Fu, Y; Kee, I; Ong, LC; Ranganath, SH; Wang, CH; Yu, S; Zhan, W; Zheng, L | 1 |
| Evangelista, L; Pasquale, R | 1 |
| Andersson, M; Johansson, L; Leide-Svegborn, S; Mattsson, S; Minarik, D | 1 |
| Doyle-Lindrud, S | 1 |
| Azad, GK; Cook, GJ | 1 |
| Goineau, A; Supiot, S | 1 |
| Balogova, S; Calzada, M; Cassou-Mounat, T; Devaux, JY; Garderet, L; Huchet, V; Kerrou, K; Mohty, M; Nataf, V; Talbot, JN | 1 |
| Barbarisi, M; Calabria, FF; Cascini, GL; Gangemi, V; Grillea, G | 1 |
| Krause, BJ; Schiemann, M; Schwarz, T; Seidl, C; Senekowitsch-Schmidtke, R | 1 |
| Chen, Z; Guo, G; Liu, J; Liu, L; Wang, D; Wang, T; Zhao, L | 1 |
| Lan, X; Li, J; Qin, C; Sun, X; Wu, Z | 1 |
| Chotipanich, C; Kunawudhi, A; Promteangtrong, C; Sricharunrat, T; Tungsuppawattanakit, P; Wongsa, P | 1 |
| Bolcaen, J; Boterberg, T; De Vos, F; Deblaere, K; Descamps, B; Goethals, I; Kalala, JP; Lybaert, K; Moerman, L; Van den Broecke, C; Vanhove, C | 1 |
| Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A | 1 |
| Gianolli, L; Incerti, E; Mapelli, P; Picchio, M | 1 |
| Gauthé, M; Gilbeau, L; Hugentobler, A; Talbot, JN | 1 |
| Beaulieu, A; Beauregard, JM | 1 |
| Narayan, N; Owen, DR; Taylor, PC | 1 |
| Baratto, L; Iagaru, A; Sonni, I | 1 |
| Castro, AC; Mamede, M; Paulino, E; Ribeiro, TH; S, R | 1 |
| Fellner, FA; Gabriel, M; Hatzl, M; Röper-Kelmayr, JC | 1 |
| Costa, G; Lapa, P; Lima, JP; Marques, M; Saraiva, T; Silva, R | 1 |
| Fujimoto, J; Fukushima, K; Hatano, E; Hirota, S; Kanematsu, A; Kato, T; Kihara, T; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nakasho, K; Nojima, M; Odawara, S; Suzumura, K; Takaki, H; Yamakado, K; Yamamoto, S; Yamano, T | 1 |
| Arnous, MMR; Hu, F; Lan, X; Qin, C | 1 |
| Decazes, P; Dubray, B; Thureau, S; Vera, P | 1 |
| Allaire, M; Amaddeo, G; Azoulay, D; Baranes, L; Calderaro, J; Chalaye, J; Costentin, CE; Duvoux, C; Ganne-Carrié, N; Itti, E; Luciani, A; Mallat, A; Nahon, P; Nault, JC; Seror, O; Soussan, M | 1 |
| Chen, TC; Lin, G; Lin, KJ; Wang, F; Yeh, TS; Yen, TC | 1 |
| Cholewinski, W; Czepczynski, R; Pietrzak, AK; Wierzchoslawska, E | 1 |
| Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S | 1 |
| Emery, S; Fraysse, M; Hallouard, F; Rioufol, C; Sauze, W; Skanjeti, A | 1 |
| De Leiris, N; Djaileb, L; Leenhardt, J; Riou, L; Vuillez, JP | 1 |
| Hu, F; Lan, X; Liu, F; Qin, C; Xia, X | 1 |
| Burger, IA; Ghafoor, S; Vargas, AH | 1 |
| Calandriello, L; Caldarella, C; Manfredi, R; Minordi, LM; Ripani, D | 1 |
| Amaddeo, G; Calderaro, J; Chalaye, J; Galletto Pregliasco, A; Itti, E; Kharrat, R; Kobeiter, H; Laurent, A; Legou, F; Luciani, A; Mulé, S; Regnault, H; Tacher, V; Tenenhaus, A | 1 |
| Garderet, L; Martino, S; Montravers, F; Talbot, JN; Zhang-Yin, J | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Lyburn, ID; Nawwar, AA; Searle, J; Singh, R | 1 |
| Bolcaen, J; Boterberg, T; De Vos, F; Deblaere, K; Descamps, B; Goethals, I; Hallaert, G; Van den Broecke, C; Vanhove, C | 1 |
| Behr, SC; Calais, J; Eiber, M; Emmett, L; Fendler, WP; Hofman, MS; Hope, TA; Lawhn-Heath, C; Rowe, SP; Salavati, A | 1 |
| Alitto, AR; Caldarella, C; Cocciolillo, F; Taralli, S | 1 |
| Myers, DT | 1 |
| Attygalle, A; Chau, I; Cunningham, D; El-Sharkawi, D; Goldman, A; Iyengar, S; Kowa, JY; Li, S; Mackinnon, A; Mahalingam, P; Marshall, K; Millard, T; Nicholson, E; Rich, P; Sharma, B; Sharma, RK; Welsh, L | 1 |
| Nguyen, BD | 1 |
| Bretonnier, M; Carsin Nicol, B; Farce, J; Girard, A; Lecouillard, I | 1 |
| Dong, Y; Han, Y; Wu, H; Zhou, W | 1 |
| Ah-Thiane, L; Ferrer, L; Fleury, V; Le Thiec, M; Maucherat, B; Rousseau, C; Rusu, D | 1 |
| Helbich, TH; Pinker, K; Romeo, V | 1 |
| Adam, R; Allard, MA; Azoulay, D; Besson, FL; Cherqui, D; Ciacio, O; Ghidaglia, J; Golse, N; Gomez, L; Lewin, M; Pittau, G; Sa Cunha, A; Salloum, C; Sönmez, RE; Vibert, E | 1 |
| Besson, FL; Durand, E; Golse, N; Pascale, A; Sebagh, M; Sivapathasundaram, A | 1 |
| Hu, F; Huang, J; Lan, X; Li, C; Wu, B; Xu, Y; Yang, K; Yang, Y | 1 |
29 review(s) available for choline and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Topics: Brain; Brain Neoplasms; Choline; Fluorodeoxyglucose F18; Glioma; Methionine; Methyltyrosines; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
Topics: Acetates; Carcinoma, Renal Cell; Choline; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Staging; Nitroimidazoles; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radiopharmaceuticals | 2006 |
[PET and malignant cerebral tumors].
Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
[Clinical usefulness of positron emission tomography in prostate cancer].
Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2007 |
Non-[18F]FDG PET in clinical oncology.
Topics: Antibodies; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Medical Oncology; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Somatostatin | 2007 |
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Topics: Amino Acids; Animals; Bone and Bones; Cell Hypoxia; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Estradiol; Fluorine Radioisotopes; Fluoroacetates; Fluorodeoxyglucose F18; Glucose; Humans; Membrane Lipids; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Molecular imaging of prostate cancer.
Topics: Animals; Antigens, Neoplasm; Bombesin; Cell Line, Tumor; Choline; Dideoxynucleosides; Dihydrotestosterone; Fluorodeoxyglucose F18; GPI-Linked Proteins; Humans; Male; Membrane Glycoproteins; Molecular Diagnostic Techniques; Neoplasm Proteins; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2009 |
[Positron emission tomography and evaluation of response to targeted therapies].
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Hypoxia; Cell Proliferation; Choline; ErbB Receptors; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lipid Metabolism; Lung Neoplasms; Neoplasms; Neovascularization, Pathologic; Piperazines; Positron-Emission Tomography; Protein Biosynthesis; Protein Kinases; Pyrimidines; Radiopharmaceuticals; Receptors, Androgen; Receptors, Estrogen; TOR Serine-Threonine Kinases | 2009 |
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
Metabolic positron emission tomography imaging in cancer detection and therapy response.
Topics: Choline; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine | 2011 |
Application of metabolic PET imaging in radiation oncology.
Topics: Acetates; Carbon Radioisotopes; Carcinoma; Choline; Confounding Factors, Epidemiologic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Lymphoma; Male; Methionine; Molecular Imaging; Neoplasms; Organ Specificity; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2012 |
Bone metastases radiopharmaceuticals: an overview.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Sodium Fluoride; Somatostatin; Technetium; Thymidine; Tomography, Emission-Computed, Single-Photon | 2013 |
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Salvage Therapy | 2014 |
Clinical applications of choline PET/CT in brain tumors.
Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Glioma; Half-Life; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Pitfalls and Artifacts in the Use of PET/CT in Oncology Imaging.
Topics: Artifacts; Choline; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Metals; Motion; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Prostheses and Implants; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
New Positron-Emission Tomography/Computed Tomography Imaging for Bone Metastases
.
Topics: Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Multi-technique imaging of bone metastases: spotlight on PET-CT.
Topics: Bone Neoplasms; Choline; Contrast Media; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Image Enhancement; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2016 |
Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.
Topics: Acetates; Carbon; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
Molecular imaging of brain tumors with radiolabeled choline PET.
Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Molecular Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Influence of Four Radiotracers in PET/CT on Diagnostic Accuracy for Prostate Cancer: A Bivariate Random-Effects Meta-Analysis.
Topics: Acetates; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; ROC Curve | 2016 |
PET imaging for lymph node dissection in prostate cancer.
Topics: Acetates; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Oligopeptides; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals | 2017 |
Advances in positron emission tomography for the imaging of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Isoquinolines; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA; Rituximab; Sodium Fluoride; Synovitis | 2017 |
Imaging of Prostate Cancer Using Gallium-68-Labeled Bombesin.
Topics: Antigens, Surface; Bombesin; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorodeoxyglucose F18; Forecasting; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Bombesin | 2017 |
How to use PET/CT in the evaluation of response to radiotherapy.
Topics: Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2018 |
Multimodality Imaging of Prostate Cancer.
Topics: Aged; Antigens, Surface; Carboxylic Acids; Choline; Cyclobutanes; Disease Progression; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiparametric Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radionuclide Imaging; Theranostic Nanomedicine; Tomography, X-Ray Computed; Whole Body Imaging | 2019 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Prostate-specific Membrane Antigen PET in Prostate Cancer.
Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2021 |
Breast PET/MRI Hybrid Imaging and Targeted Tracers.
Topics: Artificial Intelligence; Breast Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
12 trial(s) available for choline and fluorodeoxyglucose f18
| Article | Year |
|---|---|
A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sarcoma, Clear Cell; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Neoplasms; Whole-Body Counting | 2003 |
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms | 2004 |
Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: comparative study with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Biological Transport; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.
Topics: Aged; Carbon Radioisotopes; Choline; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2010 |
Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
Topics: Biological Transport; Carcinoma, Hepatocellular; Cell Differentiation; Choline; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed | 2010 |
A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Topics: Aged; Carcinoma, Hepatocellular; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
Topics: Adenocarcinoma; Aged; Biopsy; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Interventional | 2014 |
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Organophosphonates; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
146 other study(ies) available for choline and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Cortical hypometabolism and its recovery following nucleus basalis lesions in baboons: a PET study.
Topics: Animals; Basal Ganglia; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Denervation; Deoxy Sugars; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Kinetics; Male; Papio; Substantia Innominata; Tomography, Emission-Computed | 1987 |
Adenovirus-dependent increase in cell membrane permeability.
Topics: Adenoviridae; Aminoisobutyric Acids; Animals; Cell Line; Cell Membrane Permeability; Choline; Chromatography, Gel; Chromatography, Thin Layer; Chromium; Deoxyglucose; Fluorodeoxyglucose F18; Hot Temperature; Methionine | 1985 |
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplastic; Choline; Creatine; Deoxyglucose; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Hydrogen; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphocreatine; Prognosis; Protons; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1999 |
Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Choline; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Phantoms, Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
Topics: Aged; Aged, 80 and over; Animals; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Isotope Labeling; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Prostatic Neoplasms; Quaternary Ammonium Compounds; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Carbon-11 choline or FDG-PET for staging of oesophageal cancer?
Topics: Carbon Radioisotopes; Choline; Esophageal Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 2001 |
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Topics: Aged; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pleural Neoplasms; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, Emission-Computed | 2002 |
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Topics: Animals; Choline; Fluorine Compounds; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured | 2002 |
Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[The usefulness of 11C-Choline-positron emission tomography in the diagnosis of sclerosing hemangioma of the lung--a case report].
Topics: Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Topics: Acetates; Adenocarcinoma; Amino Acids; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study.
Topics: Aged; Aged, 80 and over; Blood Glucose; Carbon Radioisotopes; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tuberculosis, Pulmonary | 2003 |
Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
Topics: Adult; Ankle Joint; Arthritis; Choline; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Synovitis; Tomography, Emission-Computed | 2003 |
18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET.
Topics: Animals; Autoradiography; Choline; Fluorodeoxyglucose F18; Metabolic Clearance Rate; Muscle, Skeletal; Myositis; Neoplasms; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Infections; Staphylococcal Infections; Tissue Distribution | 2004 |
[11C]choline uptake in regenerating liver after partial hepatectomy or CCl4-administration.
Topics: Animals; Carbon Radioisotopes; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Choline; Fluorodeoxyglucose F18; Hepatectomy; Liver; Liver Regeneration; Male; Metabolic Clearance Rate; Organ Size; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Thymidine; Tissue Distribution; Tritium | 2004 |
3-Nitropropionic acid-induced neurotoxicity--assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy.
Topics: Acute Disease; Animals; Behavior, Animal; Body Weight; Brain; Choline; Chronic Disease; Disease Models, Animal; Disease Progression; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Motor Activity; Neostriatum; Neurotoxicity Syndromes; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Succinic Acid; Tomography, Emission-Computed | 2004 |
In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lactic Acid; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Protons; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Statistics as Topic; Survival Analysis | 2004 |
Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
18F-choline images murine atherosclerotic plaques ex vivo.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Autoradiography; Choline; Choline Kinase; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
A simplified method to integrate metabolic images in stereotactic procedures using a PET/CT scanner.
Topics: Aged; Algorithms; Brain; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Positron-Emission Tomography; Radiosurgery; Software; Stereotaxic Techniques; Tomography, X-Ray Computed | 2005 |
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
Topics: Animals; Blood-Brain Barrier; Brain Injuries; Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tyrosine | 2006 |
PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Choline; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Clinical PET in oncology: not only FDG.
Topics: Acetates; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Medical Oncology; Methionine; Neoplasms; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Na+/Ca2+ exchanger inhibitors modify the accumulation of tumor-diagnostic PET tracers in cancer cells.
Topics: Bepridil; Calcium; Carbon Radioisotopes; Cell Line, Tumor; Choline; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Sodium; Sodium-Calcium Exchanger; Thapsigargin | 2007 |
Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells.
Topics: Acetates; Adenosine Triphosphate; Carbon Radioisotopes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Choline; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tritium | 2006 |
(1)H MR spectroscopic imaging in patients with MRI-negative extratemporal epilepsy: correlation with ictal onset zone and histopathology.
Topics: Adolescent; Adult; Aspartic Acid; Brain Mapping; Child; Choline; Creatine; Electroencephalography; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2007 |
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Topics: Animals; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Image Enhancement; Injections, Intravenous; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Whole Body Imaging | 2007 |
Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.
Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
Topics: Bone and Bones; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
In vitro and in vivo studies with [(18)F]fluorocholine on digestive tumoral cell lines and in an animal model of metastasized endocrine tumor.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Choline; Digestive System Neoplasms; Endocrine Gland Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Mice; Neoplasm Metastasis; Radionuclide Imaging | 2008 |
Fully automated [18F]fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer.
Topics: Alkylation; Bridged Bicyclo Compounds, Heterocyclic; Choline; Equipment Design; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Methylation; Radiochemistry; Radiopharmaceuticals | 2008 |
Misdiagnoses of 11C-choline combined with 18F-FDG PET imaging in brain tumours.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
Topics: Adult; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Glioma; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2008 |
Early detection of cardiac sarcoidosis: comparison of 18F-FDG PET with 11C-choline PET.
Topics: Adult; Aged; Carbon Radioisotopes; Cardiomyopathies; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2007 |
Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
Topics: Aged; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2008 |
Monitoring of early response to neoadjuvant chemotherapy in breast cancer with (1)H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Algorithms; Breast Neoplasms; Chemotherapy, Adjuvant; Choline; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Middle Aged; Neoadjuvant Therapy; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases.
Topics: Aged; Antineoplastic Agents; Carbon Radioisotopes; Choline; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Positron-emission tomography in imaging and staging prostate cancer.
Topics: Acetates; Aged; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Technetium Tc99m tetrofosmin single-photon emission CT for the assessment of glioma proliferation.
Topics: Adult; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Glioma; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2008 |
PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline.
Topics: Acetates; Animals; Carbon; Carcinoma, Hepatocellular; Choline; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Marmota; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Tomography, X-Ray Computed | 2009 |
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experience.
Topics: Aged; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Meningioma; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Characterization of preclinical models of prostate cancer using PET-based molecular imaging.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Choline; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Hormones; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Reproducibility of Results | 2009 |
Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms | 2010 |
Diabetic striatal disease: clinical presentation, neuroimaging, and pathology.
Topics: Adolescent; Aged; Aged, 80 and over; Aspartic Acid; Choline; Chorea; Corpus Striatum; Creatine; Diabetic Neuropathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome | 2009 |
Daunorubicin and doxorubicin inhibit the [(11)C]choline accumulation in cancer cells.
Topics: Carbon Radioisotopes; Cell Line, Tumor; Choline; Daunorubicin; Doxorubicin; Fluorodeoxyglucose F18; Humans | 2009 |
[Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml].
Topics: Adult; Aged; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2009 |
Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostate; Prostatic Neoplasms; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Comparison of 18F-FDG and 11C-choline PET/CT for detecting recurrences in patients with nonsquamous cell head and neck malignancies.
Topics: Biological Transport; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biopsy; Brain Neoplasms; Choline; Contrast Media; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Microcirculation; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Spin Labels; Stereotaxic Techniques | 2010 |
Imaging lipid synthesis in hepatocellular carcinoma with [methyl-11c]choline: correlation with in vivo metabolic studies.
Topics: Animals; Betaine; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Choline Kinase; Choline-Phosphate Cytidylyltransferase; Fluorodeoxyglucose F18; Lipids; Liver Neoplasms; Marmota; Phosphatidylcholines; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Utility of ¹¹C-choline imaging as a supplement to F-18 FDG PET imaging for detection of thyroid carcinoma.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
¹¹C-choline and F-18 FDG PET/CT images of hemangioblastoma.
Topics: Aged; Carbon Radioisotopes; Cerebellar Neoplasms; Choline; Fluorodeoxyglucose F18; Hemangioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Squamous Cell; Chemoradiotherapy; Choline; Cisplatin; Contrast Media; Diagnostic Imaging; Extracellular Space; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Gadolinium DTPA; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric; Tongue Neoplasms; Tonsillar Neoplasms | 2012 |
Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.
Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Creatine; Demyelinating Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Inflammation; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methionine; Middle Aged; Neuroimaging; Positron-Emission Tomography | 2011 |
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.
Topics: Aged; Analysis of Variance; Choline; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
Topics: Abdominal Neoplasms; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Transitional Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2011 |
Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?
Topics: Acetates; Androgens; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Prostatic Neoplasms | 2011 |
Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Bone Neoplasms; Carbon Radioisotopes; Cell Growth Processes; Child; Choline; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Linear Models; Male; Methyltyrosines; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2011 |
Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.
Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Choline; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Mice; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Transplantation, Heterologous | 2011 |
Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carbon Radioisotopes; Cell Proliferation; Choline; Choline Kinase; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Lesions of multiple myeloma adjacent to the skull are better visualized on F-18 fluoroethyldimethyl-2-hydroxyethylammonium (FECH) PET images than on F-18 FDG PET images.
Topics: Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Quaternary Ammonium Compounds; Skull; Tomography, X-Ray Computed | 2011 |
Metabolic signatures imaged in cancer-induced cachexia.
Topics: Animals; Brain; Cachexia; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glucose; Lung; Magnetic Resonance Spectroscopy; Male; Mice; Mice, SCID; Muscle, Skeletal; Neoplasms, Experimental; Positron-Emission Tomography | 2011 |
Comparison of MRI, F-18 FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy.
Topics: Adult; Aged; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Radiation Injuries; Tomography, X-Ray Computed; Young Adult | 2011 |
F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy.
Topics: Aged; Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kinetics; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Recurrence; Time Factors; Tomography, X-Ray Computed | 2012 |
Evaluation of deuterated 18F- and 11C-labeled choline analogs for cancer detection by positron emission tomography.
Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Choline; Deuterium; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Kidney; Kinetics; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oxidation-Reduction; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers | 2012 |
Usefulness of Choline-PET for the detection of residual hemangiopericytoma in the skull base: comparison with FDG-PET.
Topics: Choline; Fluorodeoxyglucose F18; Hemangiopericytoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skull Base Neoplasms | 2012 |
Changes in glucose metabolism and metabolites during the epileptogenic process in the lithium-pilocarpine model of epilepsy.
Topics: Animals; Aspartic Acid; Brain Mapping; Choline; Creatine; Disease Models, Animal; Epilepsy; Fluorodeoxyglucose F18; Glucose; Hippocampus; Lithium Chloride; Magnetic Resonance Spectroscopy; Male; Pilocarpine; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Time Factors; Tritium | 2012 |
Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Autoradiography; Choline; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Iodine Radioisotopes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunodetection; Radiopharmaceuticals | 2012 |
SPECT and PET imaging of meningiomas.
Topics: Acetic Acid; Adult; Ammonia; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Meningioma; Nitrogen Radioisotopes; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Technetium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tyrosine | 2012 |
Comparative study of the value of dual tracer PET/CT in evaluating breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Choline; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2012 |
Progressive multifocal leukoencephalopathy (PML) mimicking high-grade glioma on delayed F-18 FDG PET imaging.
Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Glioma; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Positron-Emission Tomography | 2012 |
Comparison of 18F-fluoro-deoxy-glucose, 18F-fluoro-methyl-choline, and 18F-DPA714 for positron-emission tomography imaging of leukocyte accumulation in the aortic wall of experimental abdominal aneurysms.
Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Autoradiography; Chemotaxis, Leukocyte; Choline; Disease Models, Animal; Fluorodeoxyglucose F18; Guinea Pigs; Leukocytes; Positron-Emission Tomography; Predictive Value of Tests; Pyrazoles; Pyrimidines; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Sensitivity and Specificity; Transplantation, Heterologous | 2012 |
Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Lymphoscintigraphy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2012 |
Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cell Proliferation; Choline; Choline Kinase; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2013 |
Recurrent prostatic adenocarcinoma with perineural spread to the lumbosacral plexus and sciatic nerve: comparing high resolution MRI with torso and endorectal coils and F-18 FDG and C-11 choline PET/CT.
Topics: Adenocarcinoma; Aged, 80 and over; Biopsy; Choline; Fluorodeoxyglucose F18; Humans; Lumbosacral Plexus; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Sciatic Nerve; Tomography, X-Ray Computed; Vascular Neoplasms | 2013 |
Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
Topics: Adult; Aged; Area Under Curve; Brain; Brain Neoplasms; Carbon Isotopes; Choline; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tissue Distribution | 2014 |
18F-fluorocholine may be taken-up by brown adipose tissue.
Topics: Adenoma; Adipose Tissue, Brown; Adult; Artifacts; Choline; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis.
Topics: Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Recurrence; Time Factors | 2014 |
Evaluation of positron emission tomographic tracers for imaging of papillomavirus-induced tumors in rabbits.
Topics: Animals; Choline; Cottontail rabbit papillomavirus; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Genome, Viral; Humans; Magnetic Resonance Spectroscopy; Neoplasms, Experimental; Papillomavirus Infections; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Tissue Distribution | 2014 |
PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine.
Topics: Affinity Labels; Animals; Biological Transport; Cell Line, Tumor; Choline; Coordination Complexes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Integrin alphaV; Integrin beta3; Integrins; Isotope Labeling; Male; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Oligopeptides; Peptides, Cyclic; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals | 2014 |
Comparative uptake of ¹⁸F-FEN-DPAZn2, ¹⁸F-FECH, ¹⁸F-fluoride, and ¹⁸F-FDG in fibrosarcoma and aseptic inflammation.
Topics: Animals; Bacterial Infections; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fibrosarcoma; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Inflammation; Male; Metabolic Clearance Rate; Mice; Organ Specificity; Organometallic Compounds; Picolinic Acids; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2014 |
Furosemide diminishes ¹⁸F-fluoroethylcholine uptake in prostate cancer in vivo.
Topics: Aged; Biological Transport; Choline; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Neoplasm Metastasis; Organ Specificity; Prostatic Neoplasms; Quality Control; Radionuclide Imaging; Retrospective Studies; Urinary Tract; Urography | 2014 |
18F-fluoroethylcholine (18F-Cho) PET/MRI functional parameters in pediatric astrocytic brain tumors.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Child; Choline; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radioactive Tracers; Radiopharmaceuticals; Rats; Recurrence; Tyrosine | 2015 |
[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Choline; Docetaxel; Drug Screening Assays, Antitumor; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inhibitory Concentration 50; Male; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhodamines; Taxoids | 2015 |
F18-Choline PET/CT: a novel tool to localize parathyroid adenoma?
Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Hypercalcemia; Hyperparathyroidism; Lipotropic Agents; Male; Parathyroid Neoplasms; Patient Selection; Preoperative Care; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2015 |
[11C-choline PET/CT in the diagnosis of prostate cancer -- Hungarian experience].
Topics: Aged; Carbon Radioisotopes; Choline; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Hungary; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
Topics: Aged; Choline; Combined Modality Therapy; Diagnosis, Differential; Early Diagnosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
Topics: Adult; Aged; Analysis of Variance; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tumor Burden | 2015 |
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome.
Topics: Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Lymph Node Metastasis from Tall-Cell Thyroid Cancer Negative on 18F-FDG PET/CT and Detected by 18F-Choline PET/CT.
Topics: Aged; Choline; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings.
Topics: Adult; Central Nervous System Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Glioma; Humans; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Magnetic Resonance Spectroscopy; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2015 |
Variability of Gross Tumor Volume in Nasopharyngeal Carcinoma Using 11C-Choline and 18F-FDG PET/CT.
Topics: Carbon Radioisotopes; Carcinoma; Choline; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Diagnostic performances of [18F]fluorocholine positron emission tomography in brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.
Topics: Choline; Elasticity Imaging Techniques; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2016 |
Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2016 |
Evidence of 18F-FCH Uptake in Human T98G Glioblastoma Cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glioblastoma; Humans; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
Topics: Aged; Aged, 80 and over; Biological Transport; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms | 2016 |
A Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Disease Models, Animal; Fluorodeoxyglucose F18; Glioblastoma; Heterografts; Humans; Image Processing, Computer-Assisted; Luminescent Measurements; Mice; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Re: Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer.
Topics: Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2016 |
ORGAN DOSES AND EFFECTIVE DOSE FOR FIVE PET RADIOPHARMACEUTICALS.
Topics: Carbon Isotopes; Choline; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Male; Phantoms, Imaging; Positron-Emission Tomography; Raclopride; Radiation Dosage; Radiometry; Radiopharmaceuticals; Software; Stochastic Processes; Tyrosine | 2016 |
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer: Reply.
Topics: Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologies.
Topics: Biological Transport; Cell Line, Tumor; Choline; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lipopolysaccharides; Macrophages; Male; Positron-Emission Tomography; Prostatic Neoplasms | 2016 |
Differences in Uptake of 18F-FDG and 11C-Choline in a Case of Acute Myeloid Leukemia.
Topics: Adult; Brain Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.
Topics: Adult; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2016 |
Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
Topics: Animals; Brain; Cell Line, Tumor; Choline; Diagnosis, Differential; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Kinetics; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2016 |
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Soft Tissue Neoplasms | 2016 |
18F-Fluorocholine PET/CT of Incidental Male Breast Cancer.
Topics: Aged; Breast Neoplasms, Male; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
How we read FCH-PET/CT for prostate cancer.
Topics: Aged; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution | 2016 |
Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT.
Topics: Choline; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Sternum | 2017 |
18F-Fluorocholine, 18F-FDG, and 18F-Fluoroethyl Tyrosine PET/CT in Parathyroid Cancer.
Topics: Aged; Choline; Female; Fluorodeoxyglucose F18; Humans; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Thyroidectomy; Tyrosine | 2017 |
[Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sodium Fluoride; Young Adult | 2017 |
Topics: Carcinoma, Renal Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Detection of Non-FDG-Avid Residual Sinonasal Malignant Melanoma in the Skull Base With 11C-Choline PET and Contrast-Enhanced MRI.
Topics: Carbon Radioisotopes; Choline; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Skull Base | 2017 |
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radiopharmaceuticals; Reproducibility of Results | 2018 |
Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Choline; Choline Kinase; Deoxycytidine; Drug Synergism; Everolimus; Fluorodeoxyglucose F18; Gemcitabine; Humans; Male; Metabolome; Mice; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2018 |
Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Technetium Tc 99m Medronate | 2018 |
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2018 |
Stability Study of [18F]Fludeoxyglucose and [18F]Fluorocholine in Different Medical Devices for Intravenous Administration.
Topics: Administration, Intravenous; Adsorption; Choline; Drug Contamination; Drug Packaging; Drug Stability; Endotoxins; Equipment and Supplies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hydrogen-Ion Concentration; Radiopharmaceuticals; Syringes | 2018 |
18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.
Topics: Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2018 |
Intense Choline Activity in Renal Cell Carcinoma Without Obvious 18F-FDG Uptake.
Topics: Carcinoma, Renal Cell; Choline; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
A Case of Primary Localized Small Bowel Amyloidosis Studied by 18F-Choline and Contrast-Enhanced 18F-FDG PET/CT.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Immunoglobulin Light-chain Amyloidosis; Intestine, Small; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Choline; Contrast Media; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2020 |
Rare Extramedullary Cardiac Involvement of Recurrent Multiple Myeloma Suspected on 18F-FDG and Confirmed on 18F-Fluorocholine.
Topics: Biopsy; Choline; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography | 2020 |
Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT-not only an FDG finding.
Topics: Choline; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; SARS-CoV-2; Vaccination | 2021 |
Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI.
Topics: Animals; Cell Line, Tumor; Choline; Contrast Media; Female; Fluorodeoxyglucose F18; Glioblastoma; Magnetic Resonance Imaging; Neoplasms, Experimental; Positron-Emission Tomography; Rats; Rats, Inbred F344 | 2021 |
Bone Marrow Activation After Chemotherapy Presenting as Diffuse Skeletal Uptake on 18F-Fluorocholine PET/CT.
Topics: Bone Marrow; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Editorial Comment: Nodal and Deltoid Uptake on FDG and
Topics: Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Are treatment response assessment maps (TRAMs) and
Topics: Central Nervous System Neoplasms; Cerebellar Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Multimodal Imaging; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Glomangiopericytoma Uptake With 99mTc-MIBI, 18F-FDG, and 11C-Choline.
Topics: Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2021 |
Intracavernous Schwannoma Characterized With 18F-FDG, 68Ga-DOTATOC, and 18F-Choline PET.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Male; Neurilemmoma; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2022 |
Superiority of 11 C-Choline PET/CT in the Delineation of a Rare Intracranial Diffuse Embryonic Tumor.
Topics: Adult; Choline; Female; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.
Topics: Ad26COVS1; Choline; Cohort Studies; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Vaccination | 2022 |
Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Choline; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies | 2023 |
Is 18 F-FDG/ 18 F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma : A Tertiary Center Dedicated Study.
Topics: Carcinoma, Hepatocellular; Choline; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Evaluation of 11 C-Choline PET/CT for T Staging and Tumor Volume Delineation in Nasopharyngeal Cancer Patients in Comparison to 18 F-FDG PET/CT.
Topics: Choline; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden | 2023 |